Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, controlled study Reply to letter to the editor
Neurol Sci
.
2023 Jan;44(1):385-387.
doi: 10.1007/s10072-022-06405-0.
Epub 2022 Sep 14.
Authors
Edoardo Ferlazzo
1
2
,
Sara Gasparini
1
2
,
Giorgia Giussani
3
,
Elisa Bianchi
3
,
Umberto Aguglia
4
5
Affiliations
1
Department of Medical and Surgical Sciences, "Magna Græcia" University of Catanzaro, Catanzaro, Italy.
2
Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, 89100, Reggio Calabria, Italy.
3
Laboratory of Neurological Disorders, Department of Neuroscience, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
4
Department of Medical and Surgical Sciences, "Magna Græcia" University of Catanzaro, Catanzaro, Italy. u.aguglia@gmail.com.
5
Regional Epilepsy Centre, Great Metropolitan Hospital, Via Melacrino, 89100, Reggio Calabria, Italy. u.aguglia@gmail.com.
PMID:
36104470
DOI:
10.1007/s10072-022-06405-0
No abstract available
Publication types
Letter
Multicenter Study
Pragmatic Clinical Trial
Comment
MeSH terms
Adult
Anticonvulsants / therapeutic use
Epilepsy* / drug therapy
Epilepsy, Generalized* / drug therapy
Humans
Prospective Studies
Substances
Anticonvulsants